Cargando…
ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells
BACKGROUND: Treatment of blast phase chronic myeloid leukemia (BP-CML) remains a challenge, and the median survival is less than 6 months. Because effective treatments are lacking, we studied tight targeting of blast crisis CML cells using adenoviral (Ad) vectors expressing a HSV-TK system under dua...
Autores principales: | Zu, Bailing, Shi, Yi, Xu, Min, You, Guoling, Huang, Zhenglan, Gao, Miao, Feng, Wenli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456766/ https://www.ncbi.nlm.nih.gov/pubmed/26017281 http://dx.doi.org/10.1186/s13046-015-0139-4 |
Ejemplares similares
-
Correction to: ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells
por: Zu, Bailing, et al.
Publicado: (2022) -
Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells
por: Li, Lei-qing, et al.
Publicado: (2013) -
Synergistic effect of resveratrol and HSV-TK/GCV therapy on murine hepatoma cells
por: Xiao, Jianyong, et al.
Publicado: (2018) -
Extramedullary blast crisis of secondary CML accompanying marrow fibrosis
por: Go, Jai Hyang, et al.
Publicado: (2012) -
HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer
por: Lifang, Yang, et al.
Publicado: (2008)